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https://doi.org/10.1016/j.mtchem2019.100230  ABSTRACT 
Dicalcium phosphate dihydrate, DCPD (CaHP04 ·2H2O), brushite, is an important calcium phosphate 
compound encountered in mineralized tissues and used in medicine, especially in bone cernent for 
mulations. However, the use of DCPD as direct implantable biomaterial has not received dedicated 
attention. In addition, the possibility to dope DCPD with biologically active ions to modulate its per 
formances was not systematically explored. We have investigated in depth the doping of DCPD with 
Mg2+, sr2+, Zn2+, Cu2+, and Ag+ ions. Clear modifications in terms of chemical composition, particl e size, 
pore distribution, crystal morphology, and affinity for water were pointed out. Then, the samples were 
cultured with human adipose derived stem cells to explore cytotoxicity and proliferation. Various be  
haviors were noticed dependent on  the incorporated metal ions. Such DCPD compounds associated with 
bioactive metal ions, and particularly Ag+ and Zn2+, appear promising as a new family of reactive ma 
terials for use, as such or in combination, in bone related applications. 1. Introduction Not only implanted CaP biomaterials may provide a biocom Calàum phosphates (CaPs) are important biominerals occurring 
in calcified tissues, whether in normal biomineralizations such as 
dentin, enamel, and bone (1-3] or in pathological processes (e.g., 
kidney and salivary calculi) (4,5]. Owing to this natural occurrence, 
CaP compounds are particularly well adapted to biomedical appli 
cations, especially in the field of regenerative medicine like in bone 
regeneration. Intense research has been dedicated to obtain bio 
materials at least as effiàent as autologous bone to achieve osseous 
tissue regeneration; one advantage of synthetic bioinspired CaP 
compounds versus bone grafts is the unlimited amount of available 
matter, a reproduàbility of physicochemical characteristics 
dictated by the synthesis conditions, and the absence of a second 
surgery to extract the bone graft. CaP biomaterials are now widely 
used for bone repair, either in the form of self supported scaffolds 
and granules (porous or dense) (6,7] - sometimes associated to an 
organic counterpart leading to composite materials (8] - or as 
coatings on prosthetic deviœs (9,10] (e.g., hip and dental implants) 
or else in the form of injectable bone œments [ 11 ]. rouet} patible substrate suited for cell activity (adhesion, proliferation, 
differentiation) but also their intrinsic bioactivity can be exploited 
to activate bone tissue repair by providing (via dissolution pro 
cesses) ionic building black, that is, calcium and phosphate ions, 
benefiàal to the construction of new bone matter. The intrinsic 
bioactivity of CaP compounds can however be further promoted by 
tailoring their chemical composition. Indeed, ionic substitution of 
calcium or phosphate ions by biologically active ions has been 
shown, for some CaP compounds, to modulate favorably their 
biological response, for example, in terms of activated osteoblastic 
activity, refrained osteoclastic action, neoangiogenesis, and so on: 
some ions are, for example, known to exhibit biological activity, 
such as magnesium, silver, strontium, copper, zinc, iron, and silicate 
ions, among others (12-19]. For example, silicated hydroxyapatite 
(SiHA) was shown to improve bone regrowth (17,20]. CaP corn 
pounds doped with Ag+, Cu2+, or Zn2+ were, for example, reported 
for their antibacterial properties (18,21-24]. Mg2+ and sr2+ were 
shown to promote osteoblasts cell proliferation, differentiation, and 
collagen synthesis, and the latter also limits osteoclastic resorption 
(25-27]. In addition, strontium may allow increasing the radio 
opacity of the implanted material (strontium being a heavier 
alkaline earth element than calàum) for an easier follow up after 
surgery (28]. The physicochemical properties, and in particular the 
solubility, of substituted CaP compounds are also bound to be
modified because of changes in the thermodynamics of the
substituted phases, as was shown recently in the case of apatites
[29].
If a large number of studies have been dedicated to incorpo
rating biologically active ions in apatite compounds (HA)
[30,31] and biomimetic non stoichiometric apatites ([19,32]), only
a limited number of reports dealt with ion substitutions in other
CaP phases: magnesium containing tricalcium phosphate is a nat
ural mineral known as whitlockite, and magnesium and strontium
doping in octacalcium phosphate, OCP, was reported [33].
Within CaP phases of interest in bone regeneration applications,
brushite, CaHPO4$2H2O (also known as dicalcium phosphate
dihydrate (DCPD)) appears as an increasingly appealing
biomaterial making compound. Brushite is a crystalline hydrated
acidic form of CaP that may occur, at least transiently, in physio
logical and pathological biomineralizations [34]. It can be used in
medicine to supply calcium and is one of the main constituents of
mineral bone cements for which the setting reaction is based on a
hydrolysis process in a multicomponent system, for example, in
association with amorphous CaP or tricalcium phosphate [35]. This
hydrolysis is because of the fact that brushite is metastable under
physiological conditions and progressively converts into HA under
physiological pH ~7.4 [36e39]. As such, it may thus be seen as a
precursor for the crystallization of biomimetic apatite directly
in vivo. However, the use of DCPD as implantable biomaterial in
bone sites d except for cement formulations (Ref. [40]) d has not
received great attention so far. In addition, the possibility to dope
DCPD with biologically active ions, for example, in view of
improving its biological performances, deserves a specific focus.
Salimi et al. [41] have reported that magnesium has no effect on the
rate of brushite formation but that it can inhibit/retard brushite
dissolution. In contrast, potassium substitution for calcium was
shown [42] to increase brushite transformation rates into HA. Zhao
et al. [22] discussed Zn doping of a DCPD coating on magnesium
substrate, pointing out antibacterial added properties. However, so
far, only few data are available on substituted brushite compounds,
and they were not obtained via an identical synthesis route which
does not allow direct comparisons of physicochemical features.
The present investigation was aimed at synthesizing and char
acterizing pure and doped brushite with cationic elements relevant
to the biomedical field and exploring cell behavior in terms of
cytotoxicity and proliferation using human adipose derived stem
cells (ADSCs). Several metal ions have been considered divalent
(Mg2þ, Sr2þ, Cu2þ, and Zn2þ) and monovalent Agþ. In each case, the
possibility to substitute calcium by these cations has been explored,
and the characteristics of the obtained compounds have been
explored by a set of complementary techniques (X ray diffraction
(XRD), Fourier transform infrared spectroscopy (FTIR), Raman
spectroscopy, scanning electron microscopy (SEM), atomic ab
sorption spectroscopy (AAS), thermal analyses (thermogravimetric
[TG]/ differential thermal analysis [DTA]), as well as particle size
distribution analyses.
2. Materials and methods
2.1. Synthesis of unsubstituted and substituted (doped) brushite
samples
Pure brushite (DCPD) crystals were obtained by precipitation
at room temperature in acidic aqueous medium, starting from
solutions of calcium nitrate tetrahydrate Ca(NO3)2$4H2O (87 g in
600 ml) and ammonium dihydrogen phosphate NH4H2PO4 (42 g
in 1400 ml). After rapid mixing, the final pH was adjusted around
5.5 via ammonia addition, then the medium was stirred for 2 hand left to mature for 3 h without stirring. The precipitate was
finally filtered, washed with deionized water, and freeze dried.
The preparation of DCPD samples doped with Mnþ cations (rep
resenting Mg2þ, Sr2þ, Cu2þ, Zn2þ, or Agþ) was carried out by
following the same protocol but replacing part of the calcium
nitrate by the doping ion nitrate, maintaining a constant cation
to phosphorus molar ratio of (Ca þ M)/P 1. In the text, the
samples produced will be referred to as Mx where M represents
the doping ion and x the mole percent of doping in the initial
precipitating solution relatively to calcium. For example, Sr5
represents the sample precipitated in the presence of 5 mol% Sr
in substitution of calcium.2.2. Physicochemical characterization
The solid compounds prepared were subjected to complemen
tary physicochemical techniques. XRD analyses were performed on
a Bruker D8 Advance diffractometer using the CuKa radiation
(l 1.5418 Å) with the following parameters: 10e55, step 0.015,
time 2s at room temperature. Themicro structural parameters were
determined by XRD pattern refinement using the DICVOL 06 option
of the FullProf® suite, based on Rietveld profile fitting procedure.
The diffraction profiles were modeled by analytical functions [42].
The estimation of the average crystallite size and microstrains was
derived from the isotropic model, and the experimental profiles
were fitted using a pseudo Voigt function. The Diamond® software
was then used for crystal structure visualization (Diamond, Version
3.0, Crystal Impact, GbR, Boon, Germany). Firstly, an automatic peak
search (and background selection) was run, inwhich peaks can also
be added manually. The system was set to a monoclinic unit cell.
The final combined peaks were saved as DICVOL *.dic file. The
backgroundwasmodeled using a linear interpolation functionwith
manually and/or automatic selected points. Secondly, the atomic
positions of the resolved structure CaHPO4$2H2O were incorpo
rated in a combined refinement of the XRD using Pearson's Crystal
Data (PCD) software. The scale factor was refined initially, followed
by the cell parameters and atomic positions. The background pa
rameters were also simultaneously refined.
FTIR spectra were recorded on a Nicolet 5700 spectrometer in
the mid infrared (IR) 400 4000 cm1 domain, using the KBr pellet
method and a resolution of 4 cm1. Complementary vibrational
information was obtained by Raman spectroscopy (LABRAM HR
800), with a laser wavelength of 633 nm.
The cationic composition of doped and undoped samples was
determined by AAS (in flame mode) using an Analytik Jena AG
contrAA 300 high resolution continuum source spectrometer.
Initial dissolution of the compounds was undergone by acidifica
tion with nitric acid addition until a pH close to ~2.
Thermal analyses (TG DTA) were performed in synthetic air,
using a Setaram SETSYS evolution system, typically with a heating
rate in the range 5e7 C/min, from 30 C to 900C.
Morphological analyses for pure and doped brushite samples
with different amounts of cationic substituent were carried out by
SEM using a LEO 435 VP at a voltage of 8e10 kV equipped with an
IMIX Energy dispersive X ray analysis (EDX) elemental analyzer.
Dynamic light scattering (DLS) measurements were carried out
after resuspension in water, using a Malvern Nano Zetasizer ZS
instrument operated at a wavelength of 633 nm and using a fixed
scattering angle of 137.2.3. Cell culture
All in vitro tests performed in this work were run on powder
consolidated pellets (15 mm in diameter and 5 mm height).
Table 1
Refined parameters from XRD data on unsubstituted brushite.
Chemical formula CaHPO4 2H2O
Crystal system Monoclinic
Space group P 2/m
Unit cell parameters a 5.816 ± 0.001 Å
b 15.193 ± 0.003 Å
c 6.244 ± 0.002 Å
b 116.393 ± 0.015
Unit cell volume 494.222 ± 0.015 Å3
Multiplicity Z 4
Reliability factors Bragg R-factor: 0.971
RF- Factor:1.59
Rp 8.75, R wp 8.38,
R exp 2.82
Zero-shift 0.005
XRD X-ray diffraction.2.3.1. Stem cell isolations
The procedure described in the following is adapted from Santos
et al. [58]. Briefly, previous cryogenically stored ADSCs were
revived in 5 ml of Dulbecco modified eagle medium (DMEM)
Glutmax/F12 (Gibco) with 10% fetal bovine serum (Invitrogen) and
1% antibiotics/antimycotics (ABAM) (Invitrogen) and incubated at
37 C at 5% CO2 for 48 h until ADSCs adhered to the culture flask.
Non adherent cells were eliminated by replacing the media. ADSCs
were passaged 3e5 times by detaching cells with TrypLE Express
(Gibco) and before being used in experiments. This research was
conducted under the University of Technology Human Research
Ethics Committee approval (UTS HREC 2013000437).
2.3.2. DCPD samples in cell culture
All DCPD samples, with and without metal ion substitution,
were UV sterilized on all surfaces then were placed into sterile 24
well cell culture dish. Once DCPD was prepared for tissue culture,
the ADSCs were seeded at a density of 20000 cells/ml. Cells were
incubated at 37 C at 5% CO2 for 14 days with media changed every
84 h (~3.5 days). The aspirated media was collected in 1.7 ml
Eppendorf tubes and placed in 80 C storage until further cytox
ocity and alkaline phosphatase (ALP) analysis.
2.3.3. Cytotoxicity assay
Briefly, media collected at 84 h intervals, at 0, 84, 168, 252, and
336 h (i.e. 0, 3.5, 7, 10.5, and 14 days, respectively) were analyzed in
triplicates of 100 ml as placed in a 96 well dish with 10 ml of resa
zurin from the Alamar Blue kit and incubated for 2 h at 37 C. The
plate was then scanned on a Tecan spectrophotometer at a mea
surement wavelength of 575 nm with a 9 nm bandwidth and a
reference wavelength scan at 600 nm with a 9 nm bandwidth.
Absorbance vs. time graphs were generated to examine relative
cytotoxicity for each DCPD sample with ADSCs.
2.3.4. ALP activity assay
ALP is widely used as a measure of stem cell proliferative ca
pacity and a marker to show pluripotency. From the collected
conditioned media at the chosen time points, 50 ml of media was
combinedwith 50 ml of p nitrophenyl (p NNP), the substrate for the
colorimetric assay, and absorbance was measured at 405 nm on a
Tecan spectrophotometer. As ALP is continuously expressed in
dividing stem cells, a relative abundance of secreted ALP can be
used to determine the cell population's proliferation in the pres
ence of cell culture additives, in this case the DCPD variants. A
steady increase in ALP detection across time points indicates a
continuous cell growth, increases can be attributed to higher
cellular activity and osteodifferentiation, whereas a decrease may
be correlated to lower cellular activity.
2.3.5. SEM of ADSCs on sample surfaces
At the final time point of 14 days, the Zn5 DCPD sample with
ADSCs was rinsed briefly in 1x phosphate buffered saline and fixed
in 4% formaldehyde for 30 min. The sample was then sequentially
dehydrated with a 10% incremental increase of ethanol in a graded
ethanol series of 20%, 30%, 50%, 70%, 80%, 90%, 96% and two ex
changes of 100% ethanol. A 1:1 mixture of absolute ethanol: hex
amethyldisilazane (HMDS) was then added followed by two
exchanges in 100% HMDS (Sigma Aldrich), allowing the final vol
ume to dry completely for at least 24 h in a vacuum chamber. The
scaffold was then mounted onto specimen stubs with adhesive
carbon tape and silver paint (ProSciTech, Australia) and optionally
coated in a ~10 nm layer of carbon using a MED 010 Balzers Union
Carbon Coater. Images were taken using a Zeiss Supra 55VP mi
croscope equipped with an in lens detector at an accelerating
voltage of 5 kV.3. Results and discussion
In the first stage, the physicochemistry of brushite samples
doped with the various metal ions was investigated in detail. In the
second stage, in vitro cell tests were carried out.
3.1. Unsubstituted brushite CaHPO4 2H2O
The XRD pattern corresponding to the unsubstituted CaP pow
der prepared here at room temperature confirmed that the product
obtained was highly crystalline and composed of a unique DCPD
phase (Supplementary Information, Figure SI1, with reference to
JCPDS datafile #72e0713). No secondary crystallized phases or
impurities were detected. Maximum peak intensities were found,
for example, for 2q values around 11.66, 20.95, and 29.28,
attributable to the diffracting planes (020), (12 1), and (11 2) of
DCPD, respectively. The XRD pattern shows an exacerbated (020)
line indicating significant preferred orientations of stacked
constitutive crystallites, as is common with brushite crystals.
In a subsequent step, crystal structure refinement has been
performed. Indexation of the powder XRD data was confirmed for
the unsubstituted brushite using the auto indexing program DIC
VOL implemented in the FullProf program [43] as described in the
experimental section. The present compound was confirmed to be
single phased, all peaks being identified in the monoclinic struc
ture of brushite. Refinement was performed using the atomic po
sitions in the P2/m (Z 4) space group, injecting as initial
parameters those obtained via PCD software. From the first search
match procedure, the CaHPO4$2H2O phase was found with all
peaks identified; thus the structure was quickly confirmed as
monoclinic with P2/m space group. A suitable solution was ob
tained, and the resulting refined lattice parameters are given in
Table 1. These results are in good agreement with structural data
reported for DCPD [44]. As Supplementary Information, Figure SI1
reports the calculated and observed peak profiles and Bragg posi
tions for unsubstituted DCPD recorded in this work. The very strong
reflection at 2q ~11.50 can be attributed to the existence of pref
erential orientation of the crystallites of the sample. In the refine
ment, it was assumed that our compound was anisotropic; this
assumption was indeed confirmed by the successful fitted
converged crystal structure.
Complementary characterizationwas provided by FTIR analyses,
and Fig. 1a reports the spectrum obtained in themid IR region 400
4000 cm1. Again, a typical shape assignable to brushite was evi
denced [45]. In particular, the OeH stretching modes of structural
water were observed with the high frequency doublet at
~3500 cm1, attributed to the antisymmetric and symmetric
stretching of loosely hydrogen bonded water molecules [46],
besides lower frequency contributions around 3300 cm1, ascribed
to the vibrations of water molecules stronger hydrogen bonding
environment [47]. The HeOeH bending of water is also visible
around 1640 cm1. Then, between 500 and 1400 cm1, a series of
bands can be distinguished and ascribed essentially to the ʋ3 PO4
and ʋ4 PO4, as well as the PeOH band around 874 cm1 (see Fig. 2
and ref. [48]).
To complement further the vibrational spectroscopy analysis, a
Raman spectrum was also recorded in the range 400e4000 cm1,
as well as zooms in the 650 1200 cm1 and 300 650 cm1 region
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Fig. 1. Vibrational spectroscopy analysis of unsubstituted brushite: a) FTIR spectrum with
spectroscopybands are observed in particular at 987 (ʋ1 PO4), 901 (PeOH str. of
HPO42), and at 1062 and 1086 cm1 (ʋ3 PO4). In the 300 650 cm1
region, the Raman spectrum exhibits bands especially at
587 cm1assignable to the ʋ4 PO4 bending mode. In addition,
Raman bands are detected at 380 and 411 cm1 and are assigned to
the ʋ2 PO4 bending [48]. Similar results were observed for pure
DCPD by Petrov et al [46].
The above XRD, IR, and Raman spectra confirm the brushitic
nature of the prepared compound. The morphology of the obtained
unsubstituted DCPD crystals was then investigated by SEM. Mi
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main band assignments and b) Raman spectrum. FTIR Fourier transform infrared
Fig. 2. XRD patterns of doped DCPD samples: a) Mg-DCPD from 5 to 50% (initial doping rate in precipitation medium), b) Sr-DCPD from 5 to 50%, c) Zn-DCPD from 2 to 50%, d) Cu-
DCPD from 5 to 20%, and e) Ag-DCPD from 5 to 20%. XRD X-ray diffraction, DCPD dicalcium phosphate dihydrate.well defined elongated platelet morphology characteristic of
brushite [48], with micron size dimensions typically of the order of
3e10 mm. EDX spectra confirmed the presence of Ca, O, and P ele
ments, as expected. To follow the thermal behavior of the synthetic
DCPD precipitated, and especially determine the amount of waterassociated to the produced sample, TG and DTA) analyses were
carried out (Supplementary Information, Figure SI2b). The TG curve
points out the existence of four different weight losses, with three
successive mass losses in the temperature range 90e300 C (peak
maxima around 120, 136, and 190 C) followed by a fourth weight
Table 2
Initial and experimental chemical analysis from AAS for doped and selected undo-
ped DCPD.
% initial (synthesis) (Ca þ M)/P M/(Ca þ M) % exp
DCPD (pure) 0.99 0 0
Mg doping (M ¼ Mg)
5% 1.1 0.00 (0) 0
10% 1.11 0.00 (1) 0.1
20% 1.09 0.00 (7) 0.7
Cu doping (M ¼ Cu)
5% 0.90 0.04 (7) 4.7
10% 0.96 0.10 (8) 10.8
20% 1.19 0.24 (2) 24.2
Sr doping (M ¼ Sr)
5% 1.04 0.02 (8) 2.8
10% 1.03 0.04 (7) 4.7
20% 1.03 0.12 (4) 12.4
Zn doping (M ¼ Zn)
2% 1.19 0.01 (2) 1.2
5% 1.17 0.03 (2) 3.2
10% 1.22 0.07 (7) 7.7
Ag doping (M ¼ Ag)
2% 1.11 0.02 (5) 2.5
5% 1.08 0.05 (6) 5.6
10% 1.09 0.11 (0) 11
DCPD dicalcium phosphate dihydrate, AAS atomic absorption spectroscopy.loss from 370 to 470 C. The three first losses are associated to
endothermic events on the DTA curve and can be linked to the
departure of water with final obtainment of monetite CaHPO4. In
contrast, the fourth weight loss, also endothermic, is related to the
condensation of HPO42 ions into pyrophosphates P2O74. An
exothermic event can also be noticed around 565 C with no asso
ciated weight loss, which can be assigned to the crystallization of
calcium pyrophosphate. The observation of several thermal events
during brushite dehydration is in accordance with the previous
data [49,50]. The total water loss reaches 24.4 wt% (corresponding
to ~2.4(4) moles H2O) which may be compared with the
theoretical 20.9 wt% corresponding to 2 mol of structural water
per unit formula. These findings remind those of Yasue et al. [50]
relative to the dehydration of synthetic brushite, which pointed out
the presence of additional H2O (about 0.5 mol in their conditions)
referred to as ‘condensation water’. Our results agree with this
observation. They suggest (for the synthetic DCPD phase precipi
tated in this work) the presence of additional water, possibly
confined in the large interplatelet spaces formed between adjacent
crystals. This condensation water most probably accounts for (at
least a good part of) the first endothermic peak at 120 C, with an
onset as low as ~ 90C.
This whole set of characterization data showed a very good
match with published data on brushite and allowed a complete
characterization, confirming the validity of the protocol used here
to precipitate pure DCPD. All the aforementioned data will then
serve as reference in the following, where potential modifications
due to the presence, in the precipitating medium, of cations Mnþ
other than calcium will be examined.3.2. Brushite doping with bioactive metal ions
In the following part, different cationic species (Mg2þ, Sr2þ,
Zn2þ, or Agþ) have been added in the precipitating medium, at
increasing concentrations (given in mole % of the initial ionic
contents in the precipitation medium), so as to unveil possible
modifications of the physicochemistry of precipitated crystals.
Table 2 reports the initial and experimental amounts of doping ion
relative to the prepared samples, the latter being determined from
AAS. These findings indicate that, in our synthesis conditions, some
elements (strontium, copper, silver, and to a lesser extent zinc)
were present in quantifiable amounts, up to 24 mol %, in the
precipitated solids, whereas others (especially magnesium) were
significantly less detectable.
In the following, to facilitate the reading, the samples will
continue to be referenced using the initial molar doping %, exper
imental values being accessible in Table 2.3.2.1. X ray diffraction/structural analysis
In the next stage, powder XRD analyses were run on each
sample to determine the nature of crystallized phases in presence.
In the case of Mg doping, the obtained XRD patterns of brushite
and Mg doped samples, denoted (Ca,Mg)HPO4$2H2O, are shown in
Fig. 2a. Samples with initial molar ratios up to 20% (Mg5 to Mg20)
where found to exhibit XRD patterns corresponding to the brushite
phase with slight variations in peak position and/or width, sug
gesting some degree of incorporation of Mg2þ ions into the DCPD
lattice. For larger Mg concentrations in the precipitation medium,
for example, at substitution ratio of 50%, a secondary phase appears
especially detectable at 2q 15.86 and 21.50, which could be
identified as struvite, MgNH4PO4$6H2O (JCPDS file #00 015 0762).
Rietveld refined unit cell parameters are gathered in Table 3,
unveiling nearly constant values up to 20% initial doping rate.
Incorporation of magnesium into DCPD thus does not seem to beeffective in our experimental conditions, as only traces appear to
substitute for calcium, in agreement with the AAS data.
The XRD patterns obtained for doping with another alkaline
earth element, strontium, are depicted in Fig. 2b. Well defined
peaks corresponding to the brushite phase are observed in all
cases. However, the presence of a secondary phase identified as
SrHPO4 (JCPDS file #00 012 0368) progressively appears from Sr20
and becomes clearly visible for Sr50. Up to 20%, these samples
exhibited very similar line profiles with a small shift in position and
variation in intensity. Results obtained from Rietveld refinement
have been added in Table 3, indicating unit cell parameters with a
general increasing tendency of parameters a, b, and c when
compared with those of pure DCPD, and these results agree well
with the reported data [51]. This observation, coupled to the AAS
data of Table 2 pointing to the presence of Sr as doping element in
all samples, confirms the Sr incorporation into brushite crystal
lattice, and these findings agree well with the larger ionic radius of
strontium (~1.16 Å [52]) than that of calcium (~1.00 Å). Such Sr
doped DCPD compounds could prove helpful for increasing bone
forming ability because of the promoting effect of Sr2þ ions on
osteoblast cells and their inhibiting role on osteoclastic resorption.
In a similar approach, doping with transitionmetal ions was also
investigated. Zinc substituted brushite samples were tentatively
prepared, and the obtained XRD patterns are shown in Fig. 2c. For
initial doping rates up to 10%, detected peaks correspond to a
brushite phase. In contrast, sample Zn20 clearly showed the
copresence of zinc phosphate Zn3(PO4)2$4H2O (JCPDS file #01 070
1908). Intermediate doping rates between 5% and 20% start to show
increasing traces of this secondary phase. The unit cell parameters
of the Zn doped DCPD phase in these samples were shown to
exhibit values close to those of pure DCPD as shown in Table 3.
These findings along with the AAS data from Table 3 indicate that
zinc incorporation into the DCPD phase is possible, while preser
ving a single phase system for initial doping rates up to 5%. It may
however be noted that for 50% Zn in the initial mixture, the ob
tained precipitate became totally amorphous and DCPD was no
more detectable, which then tends to point out a significant crystal
growth inhibition played by Zn2þ ions for the DCPD phase. Because
the Zn2þ cation exhibits biological effects such as antibacterial and
Table 3
Refined unit cell parameters from XRD data (Rietveld approach) for doped and undoped DCPD.
% synthesis % exp a (Å) SD b (Å) SD c (Å) SD b() SD V (Å3)
DCPD (pure) 0 5.816 0.001 15.193 0.003 6.244 0.002 116.393 0.015 494.2
Mg doping
5 0 5.810 0.004 15.180 0.007 6.237 0.004 116.369 0.048 493.1
10 0.1 5.811 0.003 15.176 0.008 6.240 0.004 116.403 0.035 493.7
20 0.7 5.816 0.003 15.187 0.007 6.242 0.003 116.402 0.025 494.3
50 n.d. presence of secondary phase (struvite)
Cu doping
5 4.7 5.816 0.002 15.190 0.003 6.245 0.002 116.392 0.017 494.2a
10 10.8 5.817 0.005 15.186 0.006 6.244 0.005 116.386 0.062 494.0a
20 24.2 5.818 0.008 15.158 0.017 6.229 0.008 116.389 0.076 490.8a
Sr doping
5 2.8 5.819 0.002 15.199 0.007 6.253 0.003 116.376 0.023 495.5
10 4.7 5.821 0.001 15.209 0.004 6.256 0.002 116.360 0.012 496.4
20 12.4 presence of secondary phase (strontium hydrogenphosphate)
50 n.d. presence of secondary phase (strontium hydrogenphosphate)
Zn doping
2 1.2 5.814 0.001 15.189 0.004 6.242 0.001 116.379 0.013 493.8
5 3.2 5.813 0.001 15.190 0.003 6.241 0.001 116.378 0.008 493.7
10 7.7 5.812 0.006 15.190 0.016 6.245 0.005 116.361 0.056 493.0b
15 n.d. 5.809 0.006 15.183 0.020 6.255 0.006 116.023 0.023 494.6b
20 n.d. presence of secondary phase (zinc phosphate)
Ag doping
2 2.5 5.809 0.002 15.185 0.003 6.239 0.003 116.342 0.010 493.3c
5 5.6 presence of secondary phase (silver phosphate)
10 11 presence of secondary phase (silver phosphate)
SD standard deviation, XRD X-ray diffraction, DCPD dicalcium phosphate dihydrate.
a with additional traces of copper phosphate.
b with additional traces of zinc phosphate.
c with additional traces of silver phosphate.antiinflammatory properties, the compounds obtained typically up
to 5% may find applications for tuning the properties of DCPD
based formulations for biomedical applications.
Another element exhibiting antibacterial properties is copper in
the form of Cu2þ ions, for which a possible incorporation in DCPD
was then explored. Comparison of XRD patterns for pure DCPD and
various copper doping rates is illustrated in Fig. 2d. The presence of
a secondary phase, namely Cu3(PO4)2$3H2O (JCPDS file #00 022
0548), was noticed for all prepared samples, including as traces for
sample Cu5. Indeed, additional reflections appeared in the dif
fractogram especially at 2q 11.37 and 12.84 whose intensities
increase with the addition of Cu2þ ions in the medium. All samples
including Cu5 were also found to exhibit the light blue color
characteristic of the presence of copper ions. These findings suggest
that our experimental conditions do not allow copper incorpora
tion solely into a DCPD lattice, even for very low copper concen
trations. Attempts have been made to modulate the synthesis
conditions, especially by replacing starting reagents (NaH2PO4
instead of NH4H2PO4) and/or increasing the temperature up to 60 C
and/or the maturation time up to 20 h. However, in all cases, the
presence of copper phosphate was detected even for 5 mol % of
copper in the medium. These observations show that Cu incorpo
ration exclusively in the DCPD lattice could not be achieved even for
low copper concentrations, despite the panel of experimental pa
rameters that have been tested in this study. Nonetheless, Rietveld
refinements point out a general decreasing tendency for a, b, and c
unit cell parameters compared with pure DCPD (Table 3),
supposing a contraction of the brushite unit cell in this case. This
significant effect, well beyond the standard deviation, thus suggests
that in addition to the formation of copper phosphate, Cu2þ ions
have also been incorporated into the DCPD lattice (although the
exact distribution of these ions between the two phase cannot be
precisely given here). This unit cell shrinkage effect can be
explained by the fact that Cu2þ ions exhibit a smaller ionic radius
(~0.73 Å) than that of Ca2þ. A similar contraction effect was re
ported by Sopcak et al. [48] on brushite doped with Ni2þ ionsexhibiting a radius (~0.70 Å) close to that of Cu2þ. If desired for
biological reasons (e.g., for conferring copper related antimicrobial
activity or for favoring neoangiogenesis for bone applications), the
presence of Cu2þ ions in a DCPD based formulation would also
involve the formation of copper phosphate as secondary phase.
Besides the investigation of a possible substitution of Ca2þ ions
by other divalent cations, as previouslymentioned, interactionwith
monovalent Agþ ions was also considered in this work. Indeed,
these ions are known to exhibit strong antimicrobial potential even
at low doping rates (which was, for example, shown in nano
crystalline apatites by Vandecandelaere [53]). Such Agþ for Ca2þ
substitution should necessarily be accompanied by a charge
compensation mechanism so as to retain overall electroneutrality.
Although the possible occurrence of cationic vacancies in DCPD has
not been demonstrated to our knowledge, an eventual additional
protonation of some HPO42 anions into H2PO4 may hypothetically
be envisioned, which justifies this study. Changes in phosphate
protonation upon cationic substitutions have, for example, been
recently shown in the case of Ca doped EuPO4 compounds [54]. The
XRD patterns of samples precipitated in the presence of silver are
displayed in Fig. 2e with starting percentage from 2% to 50%. The
presence of the DCPD phase as main phase is confirmed by the
observed diffractions peaks. However, a secondary phase was also
identified (Fig. 2e), in increasing amounts for increasing Ag doping
rates, which is especially detectable at 2q 29.70, 33.30, and
33.66. This secondary phase, even present as traces in sample Ag2,
could be identified as silver phosphate Ag3PO4 (JCPDS file #01 089
7399). This fact is also probably related to the observation of a
yellow tint for all samples precipitated in this work in the presence
of silver. These results indicate that the incorporation of silver into
brushite lattice did not prove to be effective, and silver doping thus
appears to be only feasible in the form of an intimate association
with an Ag3PO4 secondary phase. This latter compound as such was
reported to exhibit antibacterial properties [55,56]. Moreover, sil
ver phosphate was also used in recent advances on injectable bone
cement formulations based on brushite and vaterite so as to convey
an antibacterial activity to the starting precipitation medium
[21,57]. The present study shows that it is possible to obtain an
intimate mixture of the DCPD and Ag3PO4 phases in a one pot
synthesis, which could enhance existing cement formulations by
allowing better/easier mixing of starting ingredients.
The aforementioned section allowed exploring of the crys
tallochemistry of the DCPD samples obtained by precipitation in
the presence of various foreign elements to point out the actual
doping rates and determine the location of these doping ions either
in substitution site in the brushite lattice or as a secondary phase
that was systematically identified.
3.2.2. FTIR spectroscopy
FTIR spectroscopy was used here to complement the charac
terization of the precipitated compounds (Fig. 3). The bands char
acteristic of the DCPD phased were systematically detected;
moreover, for some compositions, spectral modifications were also
observed, which can be related to the previous XRD results.
In the case of Sr substitution (Fig. 3b), typical vibration bands of
brushite are detected but a clear modification of spectral features
are detected, for example, in the 800 1300 cm1 domain, which can
be related to the occurrence of the strontium hydrogenphosphate
secondary phase as shown by XRD.
In the case of Mg (Fig. 3a), all spectra remain very similar, which
is in good agreement with the XRD data showing only a very low
Mg incorporation. For Mg50. however, spectral modifications are
essentially seen in the 3000e3500 and 1300 1500 cm1 domain,
which are in accordance with the presence of struvite (detected by
XRD) giving absorption bands in this region.
For zinc substitution (Fig. 3c), for Zn 2, 5, and 10, the charac
teristic bands of DCPD were obtained with only a slight displace
ment in positions and intensities. In contrast, strong spectral
modifications occur beyond 10% Zn initial doping. These alterations
can be especially visible in the vibrational domains around the OeH
stretching modes (ranging between 2500 and 4000 cm1) and in
the 500 1300 cm1 region. Although for doping rates lower than
10%, the doublet related to water is clearly visible at 3550 cm1and
3490 cm1; these bands intensities progressively decrease for
larger doping rates until being only detectable as shoulders. The
PeO vibration modes (500 1300 cm1) also show significant
modifications with the progressive formation of very broad bands
with low resolution, especially around 1070 cm1. These changes
are likely related to the formation of zinc phosphate detected by
XRD from Zn 10, which seems confirmed by the appearance of the
band centered around 1070 cm1, characteristic of this phase
Seung Ho Jung et al. [59].
Silver doped brushite samples exhibited also all the main vibra
tional peaks characteristic of the brushite phase (Fig. 3e), except for
Ag50 where significant spectral modifications were observed, espe
cially with the progressive addition of bands in the range
3300e3700 cm1 (zoom “b” on Fig. 3e) and around 500 and
1000 cm1 (zoom “c” on Fig. 3e). These bands can be explained on the
basis of the formation of silver phosphate (internal communication).
Concerning brushite samples precipitated in the presence of
copper (Fig. 3d), the spectra remained in all cases very similar to
that of pure DCPD, and no significant changes could be evidenced.
These FTIR observations thus give additional features for the
doped samples produced in this work and are in good agreement
with our conclusions drawn from the aforementioned XRD data.
3.2.3. Morphological features
To complete the physicochemical study of the precipitated
solids, SEM observations were realized on relevant selected com
pounds. As mentioned in the first section of this article, analysis of
pure DCPD pointed out the characteristic plate like morphology ofthe brushite phase with particles typically in the range 3e10 mm in
size and with a tendency for the formation of stacked superstruc
tures. In contrast, a less homogeneous morphology seems to be
noticed on ion doped precipitates. Figure SI2 reports, as Supple
mentary Information, typical morphological features observed for
each type of substituting ion. Themost contrasting effect was found
with copper and zinc doping where the general plate like aspect
was mostly lost in favor of disordered aggregated particles (Fig. 4a
and Figure SI2(f)). Other doping ions had intermediate effect: Mg
and Sr in particular led to an overall smaller particle size (Fig. 4b
and Figure SI2(b d)) and the 3D organization of the particles was
also found to be affected, with less parallel stacking and more
concretion like spherical aggregates. In the case of silver doping
(Figure SI2(e)), the platelet morphology of regular brushite was
globally retained, with however a general smaller particle size and
the additional presence of smaller aggregates that could be related
to the secondary silver phosphate phase detected previously and
responsible for the yellow coloration of the powder.
The aforementioned findings point out on the doped DCPD sam
ples a general tendency for obtaining smaller particles. To explore this
point further and confirm this SEM derived conclusion on a quanti
tative basis, particle size distributions were also analyzed in the
illustrative example of the Sr doping series. Results (Supplementary
Information, Figure SI4) show that the suspension of unsubstituted
DCPD and the first strontium percentage Sr5 has a single fairly large
size distribution centered around 397 nm. By increasing the stron
tium concentration, the monomodal distribution remained uniform
but shifted toward smaller sizes around140nm for Sr10 and Sr20 and
with a notable decrease down to 90 nm for Sr50. Therefore, the
incorporation of strontium, in this illustrative example, leads to a
quantifiable decrease of the global particle size of the samples, thus
confirming our conclusions based on direct SEM observations.
3.2.4. Thermal decomposition/dehydration behavior
Ion doped DCPD samples have also been investigated by TG/DTA
so as to evidence other possible physicochemical modifications
compared with pure DCPD. In particular, Mg and Sr doped samples
have been analyzed to complement the previously mentioned dis
cussion. All characteristic thermograms are given on Figure SI5 as
Supplementary Information. Although the global shape of the curves
remained very close to that of pure DCPD with sequential dehydra
tion/decompositionsteps,ageneral trendcouldbenotedonthese two
series of samples (Fig. 5a and b), with a totalweight loss progressively
approaching the theoretical value of 20.9 wt% (corresponding to
2 mol of structural H2O per unit formula), while undoped DCPD
exhibited also additional ~0.4(4) moles assigned to condensation
water. These observations thus suggest that less additional water is
associated to the ion doped brushite crystals compared with raw
DCPD,which is supportedby theobservationof a cleardecrease of the
120 C endotherm upon doping as illustrated for Mg on Fig. 5c. Taking
into account the results and discussion of the rest of the article, these
findings are likely related to the noticeable alteration of crystal
morphology, size, and 3D organization (leading to different
pore distributions) noticed upon ion doping and susceptible to affect
the affinity for water of the DCPD crystal surfaces.
The aforementioned findings thus indicate that, upon contact
with the cationic elements studied in this work, a variety of phys
icochemical modifications occur. In a subsequent step, first inten
tion in vitro tests were run using human ADSCs with the view to
assess cytotoxicity and proliferative patterns (through ALP assay).
3.3. In vitro cell behavior
ADSCs are mesenchymal stem cells that are sourced from the
adipose tissue and possess a multilineage potential. They are
Fig. 3. FTIR spectra for samples precipitated in the presence of a) Mg2þ ions, b) Sr2þ, c) Zn2þ (with delimitation of the O H stretching (left) and P OH stretching (right) regions), d)
Cu2þ, and e) Agþ (with a zoom on the O H stretching (left) and P OH stretching (right) regions). FTIR Fourier transform infrared spectroscopyphenotypically similar to mesenchymal stem cells (MSCs) as they
express CD29, CD44, CD71, CD90, CD105/SH2, and SH3. The aim of
these experiments was to explore the effect on ADSCs induced by
metal ion doping of DCPD. The effects examined here were cellular
responses to the scaffolds in terms of cytotoxicity, proliferation, and
cellular adherence to the surface.3.3.1. Cytotoxicity of doped DCPD on ADSCs during in vitro tissue
culture
Alamar blue cell viability reagent is a ready to use resazurin
based solution that functions as a cell health indicator by using the
reducing power of living cells to quantitatively measure viability.
Resazurin, the active ingredient of Alamar blue reagent, is a non
Fig. 4. SEM images and EDX spectrum for samples a) Cu20 and b) Sr20. SEM scanning electron microscopy, EDX Energy dispersive X-ray analysistoxic, cell permeable compound that is blue in color and virtually
non fluorescent. The reagent was directly added to the cells or to
collected conditioned media to measure relative cell viability.
Owing to the DCPD sample surface variability and sample height
and the continuous culture, secreted media were collected at 0, 3.5,
7, 10.5, and 14 days for analysis. Generally an absorbance between
0.18 and 0.28 is the average window for normal cell viability with
ADSCs displaying normal cell death. A variation up to higher
absorbance levels indicates cytotoxicity as a function of cellular
distress and/or higher cell death. Each sample triplicate mean wasplotted as absorbance vs time points. Figs. 6 and 7 present the
controls of no scaffold, the silicon disk (Si) and our pure DCPD
sample, as well as some doped DCPD with Agþ, Cu2þ, Mg2þ, Sr2þ,
and Zn2þ. These data allow us to draw comparative conclusions.
Fig. 6a revealed that pure DCPD, such as the non cytotoxic
controls, had a negligible effect on ADSCs viability, with a low
cellular cytotoxicity for most of the time points. Similarly, Fig. 6b
corresponding to the Ag doped DCPD samples reveals a congruent
graph evolution between the control and the Ag DCPD. The Ag2
























































Fig. 5. TG/OTA on Mg (a.c) and Sr (b) doped DCPD samples. DCPD dicalcium 





QJ 0.4 u 
0.3 
I 0.2 VI ;j 
< 0.1 
0 







� 0.2 ..c I < 
0.1 
0 
















Od 3.5d 7d 10.5 d 14d 
-Zn5% -Zn10%
Fig. 6. Cytotaxicity evaluation (Alamar blue resazurin assay) for controls, Ag- and Zn­
doped DCPD compounds. Samples collected at 0, 3.5, 7, 10.5, and 14 days (color figure 









Od 3.5 d 7d 10.5 d 14 d 
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Fig. 7. Cytotaxicity evaluation (Alamar blue resazurin assay) for DCPD samples doped 
with 5% (initial %) Mg, Cu, Sr, and Zn and for the empty control Samples coUected at 0, 
3.5, 7, 10.5, and 14 days (color figure accessible online) DCPD dicalcium phosphate 
dihydrate. whereas the Agl0 graph retlects a similar pattern to DCPD control. 
In any case, ail Ag doped compounds tested here exhibited a low 
cytotoxicity toward ADSCs. 
For Zn doping (Fig. Ge), the ZnS sample is assoàated to a -0.4 
absorbance maximum level reached in our experimental condi 
tions, revealing a low degree of cytotoxiàty. In contrast, at least at 
252 h, the relative cytotoxiàty in the ZnlO sample increased 
significantly, painting out a toxicity effect of Zn2+ in these 
conditions. Ali other tested compositions, containing Mg2+, Cu2+, and sr2+ 
exhibited some higher degree of cytotoxiàty toward ADSCs, with 
absorbance levels more than 0.4. For an illustrative purpose, Fig. 7 
Fig. 8. ALP assay results (color figure accessible online) ALP alkaline phosphatase
Fig. 9. SEM observation of ADSC cells in contact with the Zn5 DCPD sample. Initial
magnifications: x200 (top picture) and x400 (down picture). EHT 5 kV. The cells are
visible as a continuous monolayer covering most of the surface of the sample. DCPD
dicalcium phosphate dihydrate, SEM scanning electron microscopy, EHT electron
high tension.reports a comparison for all samples doped with an initial amount
of 5%. Up to 168 h of contact, the following relative cytotoxicity
order may be drawn for these compounds:
Ctrl < Mg5 < Zn5 < Sr5 < Cu5; at higher contact times Mg5
exhibited a noticeable increase in toxicity. This conclusion should
however be considered with precaution because the actual metal
ion contents were shown in the previous physicochemistry section
to differ from the initial 5% doping rate of the precipitation me
dium. These data nonetheless allow, from a practical point of view,
to determine the level of toxicity that is reached for the various
dopings realized in this work. In turn, this allows to predetermine
the ‘acceptable’ ranges of doping rates leading to non toxicity
whenever biomedical applications of such doped DCPD com
pounds will be envisioned. The different behaviors noticed here are
thought to be directly linked to thermodynamic modifications
undergone by calcium substitution in DCPD with these different
ions.
To explore further the biocompatibility and cell/material in
teractions involving these compounds, ALP assays were also real
ized versus contact time. ALP assays are widely used as a test for
cellular proliferation. A consistent linear increase over several time
points theoretically presents a proportional growth of cells and
secretion of ALP. ALP can also be used to monitor cells in non
transparent culture systems, as the ALP levels can be directly
correlated to proliferation in normal cellular conditions and cellular
response to environments.
For a comparative purpose, Fig. 8 presents the relative panel of
ADSCs growth via the obtained ALP titrations for the controls and
doped DCPD samples. The controls Ctrl and Si have very shallow
linear like gradients, a standard for normal ADSC proliferation over
time. The undoped DCPD control also shares a very close linear like
relationship to the controls. Similarly, both 2% and 10% Ag DCPD
and 5% and 10% Zn DCPD share shallow ALP gradients with insig
nificant variance when compared with the controls. Cu, Mg, and Sr
DCPD variable doping compositions exhibit in contrast substantial
changes in their ALP detection. The most notable increase in ALP
levels compared with the ADSCs are detected for the samples Cu5
at 7 days, Mg20 at 7 days, Sr5 at 10.5 days, Sr10 at 3.5, 7, and 10.5
days. As Supplementary Information, Figure SI6 reports a Euclidean
single linkage hierarchical clustering of ALP assay results. Generally
speaking, this type of representation groups together samples that
have a similar effect on the cells over all time points. The closer the
lines or grouping of each sample, the more similar the cellular
response. The heatmap clustering identifies a stacked order of
ADSCs ALP secretion level similarities between controls and dopedDCPD samples. The hierarchical clustering over all time points
graded into groups (1 5) reveals the samples in group 1 are Cu5,
Mg20, and Sr5 being the most variable with the highest ALP levels.
Group 2 (Ctrl and Si) shares close branch lineage to group 3, sharing
the least fluctuations in ALP levels.
The global ALP response appears in good general agreement
with the aforementioned cytotoxicity assays performed. ALP and
Alamar blue values seem to be more pronounced for certain metal
ions such as Cu2þ, Mg2þ, and Sr2þ. Doping with Agþ (for which we
showed in the physicochemistry section that it was mainly in the
form of Ag3PO4) and to a lesser extent with Zn2þ leads to DCPD
compounds significantly less stressful for ADSCs. To confirm the
cell biocompatible surface features of Zn doped DCPD, additional
observations were made by SEM after cell contact at the t 336 h
time point (Fig. 9). Despite the fixation and dehydration procedure
for SEM analysis, ADSCs were clearly found to adhere on the Zn5
sample, where a high cellular attachment and proliferation of cells
on the surface of the structure were observed. The cells seem to
have a thick spiderweb like morphology adhered to multiple an
chor points on the surface of this Zn containing DCPD sample
pointing to a non toxic situation for the cells.
4. Conclusions and perspectives
The potentiality of doping DCPD (brushite) crystals d a pre
cursor of apatite in physiological conditions d with several bio
logically relevant elements such as magnesium, strontium, zinc,
copper, and silver was investigated from a physicochemical and an
in vitro viewpoint. Some of these elements were shown to be
incorporated (Sr, Zn), in various amounts, into the DCPD phase,
while the formation of selected secondary phases was noticed in
other cases (Mg, Cu, Ag) depending on the nature and concentra
tion of doping ions. In our experimental conditions, secondary
phases of struvite MgNH4PO4$6H2O was clearly identified for a
substitution rate in the initial mixture of 50% for Mg doped DCPD,
SrHPO4 was detected beyond 20% of Sr substitution,
Zn3(PO4)2$4H2O was identified beyond 5% of Zn substitution;
finally, Cu3(PO4)2$3H2O, and Ag3PO4 were systematically detected
in all samples prepared in the presence of copper and silver ions,
respectively. However, in instances where the metal ions remained
essentially outside of the DCPD structure, such as silver, the ‘crystal
scale’ intimate mixtures obtained could prove helpful for better
homogenizing existing bone cement formulations where DCPD is
used as precursor. In addition, the secondary phases themselves
might also exhibit bioactive properties favorable to bone regrowth.
In other cases, where the metal ions were found to be accommo
dated in the DCPD structure, the single phased ‘activated’ DCPD
compounds should prove promising for future biomedical uses;
depending on the clinical application envisioned, the nature and
amount of doping ion can then be selected.
Several characteristics of the precipitated DCPD crystals were
found to be modified upon doping such as their chemical compo
sition, crystal morphology, particle size, pore distribution, as well as
their affinity for water.
Such ion substituted DCPD systems may be envisioned as
reactive CaP based compounds for use in bone repair applications,
alone or in association with other components such as polymers or
other mineral ingredients. A modulation of their biological activity,
thanks to such ionic doping (e.g., to fight infections, to control
inflammation, to promote angiogenesis, and so on), is expected,
although this is dependent on the aimed clinical application. As a
preliminary biological survey, we investigated here the biocom
patibility of such doped DCPD compounds vs. human ADSCs;
cytotoxicity and proliferative behaviors were found to depend
directly on the nature and amount of doping metal ion. These data
allow predetermining the order of magnitude of doping to select
while avoiding the occurrence of toxic events for such cells, in the
view of future biomedical uses aiming at exploiting, for example,
the antibacterial, antiinflammatory, proangiogenic, antiresorptive,
and/or other biological properties of metal ions among Agþ, Cu2þ,Zn2þ, Mg2þ, and Sr2þ. A particular attention might be paid to Ag
and Zn doped DCPD samples which were found here to be the least
stressful for ADSCs.
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Figure SI2: Characteristics of unsubstituted brushite: a) SEM micrographs and EDX 
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Figure SI3: SEM images (initial magnifications: x500 and x2000) showing the morphology 
of (a) unsubstituted DCPD, (b) Mg10-DCPD, (c) Mg20-DCPD, (d) Sr10-DCPD, (e) Ag5-





























































































































































































































































































































Figure SI6: Euclidean single linkage hierarchical clustering of ALP. The heatmap clustering 
identifies stacked order of ADSCs ALP secretion level similarities between controls and 
doped DCPD samples. Groupings identified as i-v with an adjacent black line. 
 
 
 
 
 
 
